These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33605620)
41. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia. Wood GC Expert Rev Anti Infect Ther; 2011 Nov; 9(11):993-1000. PubMed ID: 22029519 [TBL] [Abstract][Full Text] [Related]
42. In Vitro Comparison of a Vibrating Mesh Nebulizer Operating in Inspiratory Synchronized and Continuous Nebulization Modes During Noninvasive Ventilation. Michotte JB; Staderini E; Le Pennec D; Dugernier J; Rusu R; Roeseler J; Vecellio L; Liistro G; Reychler G J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):328-36. PubMed ID: 27310926 [TBL] [Abstract][Full Text] [Related]
43. Short-course versus prolonged-course antibiotic regimens for ventilator-associated pneumonia: A systematic review and meta-analysis of randomized controlled trials. Cheema HA; Ellahi A; Hussain HU; Kashif H; Adil M; Kumar D; Shahid A; Ehsan M; Singh H; Duric N; Szakmany T J Crit Care; 2023 Dec; 78():154346. PubMed ID: 37247528 [TBL] [Abstract][Full Text] [Related]
44. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria. Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805 [TBL] [Abstract][Full Text] [Related]
45. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Pugh R; Grant C; Cooke RP; Dempsey G Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771 [TBL] [Abstract][Full Text] [Related]
46. High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review. Karaiskos I; Gkoufa A; Polyzou E; Schinas G; Athanassa Z; Akinosoglou K Microorganisms; 2023 May; 11(6):. PubMed ID: 37374959 [TBL] [Abstract][Full Text] [Related]
47. Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study. Wu Z; Zhang S; Cao Y; Wang Q; Sun K; Zheng X Front Pharmacol; 2023; 14():1209063. PubMed ID: 37663252 [No Abstract] [Full Text] [Related]
48. Understanding the nebulisation of antibiotics: the key role of lung microdialysis studies. Dhanani J; Roberts JA; Monsel A; Torres A; Kollef M; Rouby JJ; Crit Care; 2024 Feb; 28(1):49. PubMed ID: 38373973 [TBL] [Abstract][Full Text] [Related]
50. Aerosolized antibiotics: do they add to the treatment of pneumonia? Kollef MH; Hamilton CW; Montgomery AB Curr Opin Infect Dis; 2013 Dec; 26(6):538-44. PubMed ID: 24126716 [TBL] [Abstract][Full Text] [Related]
51. Is inhaled prophylactic heparin useful for prevention and Management of Pneumonia in ventilated ICU patients?: The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group. Bandeshe H; Boots R; Dulhunty J; Dunlop R; Holley A; Jarrett P; Gomersall CD; Lipman J; Lo T; O'Donoghue S; Paratz J; Paterson D; Roberts JA; Starr T; Stephens D; Stuart J; Thomas J; Udy A; White H J Crit Care; 2016 Aug; 34():95-102. PubMed ID: 27288618 [TBL] [Abstract][Full Text] [Related]
52. Nebulized antibiotics for ventilator-associated pneumonia: misleading analysis and interpretation of the data. Gu WJ Crit Care; 2015 Jun; 19(1):236. PubMed ID: 26073441 [No Abstract] [Full Text] [Related]
53. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria. Cillóniz C; Dominedò C; Torres A Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412 [TBL] [Abstract][Full Text] [Related]
54. Lung Pharmacokinetics of Tobramycin by Intravenous and Nebulized Dosing in a Mechanically Ventilated Healthy Ovine Model. Dhanani JA; Diab S; Chaudhary J; Cohen J; Parker SL; Wallis SC; Boidin C; Barnett A; Chew M; Roberts JA; Fraser JF Anesthesiology; 2019 Aug; 131(2):344-355. PubMed ID: 31107274 [TBL] [Abstract][Full Text] [Related]
55. Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials. Qin JP; Huang HB; Zhou H; Zhu Y; Xu Y; Du B Sci Rep; 2021 Mar; 11(1):6969. PubMed ID: 33772055 [TBL] [Abstract][Full Text] [Related]
56. Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia. Ammar MA; Abdalla W Saudi J Anaesth; 2018; 12(1):89-94. PubMed ID: 29416463 [TBL] [Abstract][Full Text] [Related]
57. GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial. Yoshimura J; Yamakawa K; Kinoshita T; Ohta Y; Morimoto T Trials; 2018 Nov; 19(1):614. PubMed ID: 30409160 [TBL] [Abstract][Full Text] [Related]
58. Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update. Luyt CE; Bréchot N; Combes A; Trouillet JL; Chastre J Expert Rev Anti Infect Ther; 2013 May; 11(5):511-21. PubMed ID: 23627857 [TBL] [Abstract][Full Text] [Related]